SIG
TEVA icon

Sargent Investment Group’s Teva Pharmaceuticals TEVA Stock Holding History

Sargent Investment Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.55M Buy
134,330
+4,000
+3% +$133K 0.55% 41
2026
Q1 		$3.93M Buy
130,330
+1,660
+1% +$53.4K 0.52% 48
2025
Q4 		$4.02M Buy
128,670
+50
+0% +$1.23K 0.5% 44
2025
Q3 		$2.6M Sell
128,620
-5,675
-4% -$99.7K 0.37% 57
2025
Q2 		$2.15M Buy
134,295
+36,000
+37% +$581K 0.29% 66
2025
Q1 		$1.51M Sell
98,295
-1,000
-1% -$17.9K 0.24% 74
2024
Q4 		$2.03M Sell
99,295
-10,005
-9% -$182K 0.33% 62
2024
Q3 		$1.97M Sell
109,300
-13,280
-11% -$232K 0.35% 58
2024
Q2 		$1.99M Sell
122,580
-2,000
-2% -$30.8K 0.41% 52
2024
Q1 		$1.76M Sell
124,580
-2,520
-2% -$31.8K 0.39% 56
2023
Q4 		$1.33M Hold
127,100
– – 0.29% 70
2023
Q3 		$1.3M Sell
127,100
-18,075
-12% -$168K 0.31% 67
2023
Q2 		$1.09M Sell
145,175
-169,500
-54% -$1.37M 0.27% 75
2023
Q1 		$2.87M Buy
314,675
+6,000
+2% +$59.3K 0.76% 34
2022
Q4 		$2.82M Buy
308,675
+22,000
+8% +$192K 0.87% 30
2022
Q3 		$2.48M Buy
286,675
+71,580
+33% +$633K 0.77% 35
2022
Q2 		$1.62M Buy
+215,095
New +$1.87M 0.5% 52
2022
Q1 		– Sell
-52,550
Closed -$439K – 199
2021
Q4 		$421K Buy
52,550
+50,000
+1,961% +$451K 0.1% 131
2021
Q3 		$25K Hold
2,550
– – 0.01% 191
2021
Q2 		$25K Buy
+2,550
New +$27K 0.01% 204

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Sargent Investment Group's TEVA Position: Q2 2026 in Review

Sargent Investment Group increased its Teva Pharmaceuticals (TEVA) stake by 3.1% in Q2 2026, buying an estimated $133K and bringing the position to 134,330 shares worth $4.55M. The position accounts for 0.55% of the portfolio, ranked #41.

Sargent Investment Group first reported a position in TEVA in Q2 2021 and has held it in 20 quarters since. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Sargent Investment Group held 134,330 shares of Teva Pharmaceuticals worth $4.55M as of Q2 2026.
  • Sargent Investment Group bought 4,000 Teva Pharmaceuticals shares in Q2 2026, an estimated $133K.
  • Teva Pharmaceuticals made up 0.55% of Sargent Investment Group's portfolio in Q2 2026, its #41 holding.
  • Sargent Investment Group first reported a position in Teva Pharmaceuticals in Q2 2021 and has held it in 20 quarters since.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Sargent Investment Group's 13F filing for Q2 2026, filed 11 Aug 2026.